208 research outputs found
The GlueX DIRC Project
The GlueX experiment was designed to search for and study the pattern of
gluonic excitations in the meson spectrum produced through photoproduction
reactions at a new tagged photon beam facility in Hall D at Jefferson
Laboratory. The particle identification capabilities of the GlueX experiment
will be enhanced by constructing a DIRC (Detection of Internally Reflected
Cherenkov light) detector, utilizing components of the decommissioned BaBar
DIRC. The DIRC will allow systematic studies of kaon final states that are
essential for inferring the quark flavor content of both hybrid and
conventional mesons. The design for the GlueX DIRC is presented, including the
new expansion volumes that are currently under development.Comment: 8 pages, 6 figure
Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment
Interstitial fibrosis plays a key role in the development and progression of
heart failure. Here, we show that an enzyme that crosslinks collagen—Lysyl
oxidase-like 2 (Loxl2)—is essential for interstitial fibrosis and mechanical
dysfunction of pathologically stressed hearts. In mice, cardiac stress
activates fibroblasts to express and secrete Loxl2 into the interstitium,
triggering fibrosis, systolic and diastolic dysfunction of stressed hearts.
Antibody-mediated inhibition or genetic disruption of Loxl2 greatly reduces
stress-induced cardiac fibrosis and chamber dilatation, improving systolic and
diastolic functions. Loxl2 stimulates cardiac fibroblasts through PI3K/AKT to
produce TGF-β2, promoting fibroblast-to-myofibroblast transformation; Loxl2
also acts downstream of TGF-β2 to stimulate myofibroblast migration. In
diseased human hearts, LOXL2 is upregulated in cardiac interstitium; its
levels correlate with collagen crosslinking and cardiac dysfunction. LOXL2 is
also elevated in the serum of heart failure (HF) patients, correlating with
other HF biomarkers, suggesting a conserved LOXL2-mediated mechanism of human
HF
Recommended from our members
Amphiphilic Copolymers for Versatile, Facile, and In Situ Tunable Surface Biofunctionalization
Precision surface engineering is key to advanced biomaterials. A new platform of PEGylated styrene-maleic acid copolymers for adsorptive surface biofunctionalization is reported. Balanced amphiphilicity renders the copolymers water-soluble but strongly affine for surfaces. Fine-tuning of their molecular architecture provides control over adsorptive anchorage onto specific materials-which is why they are referred to as "anchor polymers" (APs)-and over structural characteristics of the adsorbed layers. Conjugatable with an array of bioactives-including cytokine-complexing glycosaminoglycans, cell-adhesion-mediating peptides and antimicrobials-APs can be applied to customize materials for demanding biotechnologies in uniquely versatile, simple, and robust ways. Moreover, homo- and heterodisplacement of adsorbed APs provide unprecedented means of in situ alteration and renewal of the functionalized surfaces. The related options are exemplified with proof-of-concept experiments of controlled bacterial adhesion, human umbilical vein endothelial cell, and induced pluripotent cell growth on AP-functionalized surfaces
Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment
Interstitial fibrosis plays a key role in the development and progression of heart failure. Here, we show that an enzyme that crosslinks collagen-Lysyl oxidase-like 2 (Loxl2)-is essential for interstitial fibrosis and mechanical dysfunction of pathologically stressed hearts. In mice, cardiac stress activates fibroblasts to express and secrete Loxl2 into the interstitium, triggering fibrosis, systolic and diastolic dysfunction of stressed hearts. Antibody-mediated inhibition or genetic disruption of Loxl2 greatly reduces stress-induced cardiac fibrosis and chamber dilatation, improving systolic and diastolic functions. Loxl2 stimulates cardiac fibroblasts through PI3K/AKT to produce TGF-β2, promoting fibroblast-to-myofibroblast transformation; Loxl2 also acts downstream of TGF-β2 to stimulate myofibroblast migration. In diseased human hearts, LOXL2 is upregulated in cardiac interstitium; its levels correlate with collagen crosslinking and cardiac dysfunction. LOXL2 is also elevated in the serum of heart failure (HF) patients, correlating with other HF biomarkers, suggesting a conserved LOXL2-mediated mechanism of human HF
Ultra-fast yttrium hydride chemistry at high pressures via non-equilibrium states induced by x-ray free electron laser
Controlling the formation and stoichiometric content of desired phases of
materials has become a central interest for the study of a variety of fields,
notably high temperature superconductivity under extreme pressures. The further
possibility of accessing metastable states by initiating reactions by x-ray
triggered mechanisms over ultra-short timescales is enabled with the
development of x-ray free electron lasers (XFEL). Utilizing the exceptionally
high brilliance x-ray pulses from the EuXFEL, we report the synthesis of a
previously unobserved yttrium hydride under high pressure, along with
non-stoichiometric changes in hydrogen content as probed at a repetition rate
of 4.5\,MHz using time-resolved x-ray diffraction. Exploiting non-equilibrium
pathways we synthesize and characterize a hydride with yttrium cations in an
\textit{A}15 structure type at 125\,GPa, predicted using crystal structure
searches, with a hydrogen content between 4.0--5.75 hydrogens per cation, that
is enthalpically metastable on the convex hull. We demonstrate a tailored
approach to changing hydrogen content using changes in x-ray fluence that is
not accessible using conventional synthesis methods, and reveals a new paradigm
in metastable chemical physics
Classification of death causes after transplantation (CLASS):Evaluation of methodology and initial results
Correct classification of death causes is an important component of transplant trials.We aimed to develop and validate a system to classify causes of death in hematopoietic stem cell (HSCT) and solid organ (SOT) transplant recipients.Case record forms (CRF) of fatal cases were completed, including investigator-designated cause of death. Deaths occurring in 2010 to 2013 were used for derivation; and were validated by deaths occurring in 2013 to 2015. Underlying cause of death (referred to as recorded underlying cause) was determined through a central adjudication process involving 2 external reviewers, and subsequently compared with the Danish National Death Cause Registry.Three hundred eighty-eight recipients died 2010 to 2015 (196 [51%] SOT and 192 [49%] HSCT). The main recorded underlying causes of death among SOT and HSCT were classified as cancer (20%, 48%), graft rejection/failure/graft-versus-host-disease (35%, 28%), and infections (20%, 11%). Kappa between the investigator-designated and the recorded underlying cause of death was 0.74 (95% CI 0.69-0.80) in derivation and comparable in the validation cohort. Death causes were concordant with the Danish National Death Cause Registry in 37.2% (95% CI 31.5-42.9) and 38.4% (95% CI 28.8-48.0) in the derivation and validation cohorts, respectively.We developed and validated a method to systematically and reliably classify the underlying cause of death among transplant recipients. There was a high degree of discordance between this classification and that in the Danish National Death Cause Registry
Tissue-specific regulatory network extractor (TS-REX): a database and software resource for the tissue and cell type-specific investigation of transcription factor-gene networks
The prediction of transcription factor binding sites in genomic sequences is in principle very useful to identify upstream regulatory factors. However, when applying this concept to genomes of multicellular organisms such as mammals, one has to deal with a large number of false positive predictions since many transcription factor genes are only expressed in specific tissues or cell types. We developed TS-REX, a database/software system that supports the analysis of tissue and cell type-specific transcription factor-gene networks based on expressed sequence tag abundance of transcription factor-encoding genes in UniGene EST libraries. The use of expression levels of transcription factor-encoding genes according to hierarchical anatomical classifications covering different tissues and cell types makes it possible to filter out irrelevant binding site predictions and to identify candidates of potential functional importance for further experimental testing. TS-REX covers ESTs from H. sapiens and M. musculus, and allows the characterization of both presence and specificity of transcription factors in user-specified tissues or cell types. The software allows users to interactively visualize transcription factor-gene networks, as well as to export data for further processing. TS-REX was applied to predict regulators of Polycomb group genes in six human tumor tissues and in human embryonic stem cells
Proliferation of Acid-Secretory Cells in the Kidney during Adaptive Remodelling of the Collecting Duct
The renal collecting duct adapts to changes in acid-base metabolism by remodelling and altering the relative number of acid or alkali secreting cells, a phenomenon termed plasticity. Acid secretory A intercalated cells (A-IC) express apical H+-ATPases and basolateral bicarbonate exchanger AE1 whereas bicarbonate secretory B intercalated cells (B-IC) express basolateral (and apical) H+-ATPases and the apical bicarbonate exchanger pendrin. Intercalated cells were thought to be terminally differentiated and unable to proliferate. However, a recent report in mouse kidney suggested that intercalated cells may proliferate and that this process is in part dependent on GDF-15. Here we extend these observations to rat kidney and provide a detailed analysis of regional differences and demonstrate that differentiated A-IC proliferate massively during adaptation to systemic acidosis. We used markers of proliferation (PCNA, Ki67, BrdU incorporation) and cell-specific markers for A-IC (AE1) and B-IC (pendrin). Induction of remodelling in rats with metabolic acidosis (with NH4Cl for 12 hrs, 4 and 7 days) or treatment with acetazolamide for 10 days resulted in a larger fraction of AE1 positive cells in the cortical collecting duct. A large number of AE1 expressing A-IC was labelled with proliferative markers in the cortical and outer medullary collecting duct whereas no labeling was found in B-IC. In addition, chronic acidosis also increased the rate of proliferation of principal collecting duct cells. The fact that both NH4Cl as well as acetazolamide stimulated proliferation suggests that systemic but not urinary pH triggers this response. Thus, during chronic acidosis proliferation of AE1 containing acid-secretory cells occurs and may contribute to the remodelling of the collecting duct or replace A-IC due to a shortened life span under these conditions
- …